Turner v. Fallon Community Health Plan, Inc.

926 F. Supp. 17, 1996 U.S. Dist. LEXIS 6782, 1996 WL 257546
CourtDistrict Court, D. Massachusetts
DecidedMay 10, 1996
DocketCivil Action No. 95-40225-NMG
StatusPublished
Cited by2 cases

This text of 926 F. Supp. 17 (Turner v. Fallon Community Health Plan, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Turner v. Fallon Community Health Plan, Inc., 926 F. Supp. 17, 1996 U.S. Dist. LEXIS 6782, 1996 WL 257546 (D. Mass. 1996).

Opinion

MEMORANDUM AND ORDER

GORTON, District Judge.

The plaintiff in the above-entitled matter, Ronald J. Turner (“Turner”), filed the instant action against defendant, Fallon Community Health Plan, Inc. (“Fallon”), alleging, inter alia, that defendant’s denial of plaintiff’s rights and benefits due under defendant’s health care policy was arbitrary and capricious in violation of ERISA, 29 U.S.C. § 1001 et seq. Pending before this Court is plaintiffs motion filed pursuant to Fed.R.CivJP. 56(f), for a continuance or other relief.

I. FACTUAL BACKGROUND

Turner, an employee of General Motors Corporation (“GM”), was appointed Administrator of the Estate of his wife, Charlotte Turner. Before she died, Mrs. Turner was entitled to receive covered health care benefits from Fallon through Turner’s employment with GM.

Mrs. Turner was diagnosed with breast cancer in 1991, and in May, 1993, tests revealed that her disease had metastasized. Dr. Ronald Hochman, Mrs. Turner’s oncologist, determined that Mrs. Turner required an autologous bone marrow transplant (“ABMT”), and recommended that she enroll in the bone marrow transplant program operated by the Dana Farber Cancer Institute (“Dana Farber”). In June, 1993, Dana Farber determined that Mrs. Turner’s cancer had spread to her bone marrow, and that as a result she did not meet the requirements for eligibility in the Dana Farber program.

The Dana Farber physicians and Dr. Hochman then recommended that Mrs. Turner enroll in the bone marrow transplant program operated by the Duke University Medical Center (“Duke”). On July 19, 1993, Duke, after analyzing the result of medical tests, determined that Mrs. Turner met the requirements for eligibility in the Duke program.

Before August 23, 1993, the Fallon Handbook, upon which Fallon bases its medical coverage decisions, provided coverage for ABMT procedures, but only for the treatment of “acute leukemia in remission, resistant non-Hodgkin’s disease, recurrent or refractory neuroblastoma, or advanced Hodgkin’s disease.” The Handbook specifically excluded coverage for “[sjervices for any transplant or condition not listed above. This includes, but is not limited to bone marrow transplant for treatment of solid tumors or pancreas transplant.”

In response to requests from Mrs. Turner and another patient of Dr. Hochman for coverage of ABMT procedures for solid tumor [19]*19cancer, Fallon’s Transplant Committee met on August 28, 1993, to review the respective protocols of the Dana Farber and Duke programs for the application of ABMT to solid tumor carcinoma. The Transplant Committee heard the medical opinions of Dr. Hochman and a Fallon surgical oncologist identified only as “Dr. Orr.” The Transplant Committee also reviewed the then current literature on the use of ABMT in connection with solid cancer tumors.

Based upon the Transplant Committee’s recommendation, Fallon extended coverage for ABMT to solid cancer tumors, but only in cases where (1) Dana Farber physicians determine that the patient meets Dana Farber’s protocol criteria, and (2) the Fallon Transplant Committee determines that the patient has a critical need for the Dana Farber transplantation procedure and there is a strong likelihood of a successful clinical outcome for the particular patient.

Mrs. Turner did not qualify for coverage under the amended Fallon Plan, because she did not meet Dana Farber’s protocol. Fallon ultimately denied Mrs. Turner’s request for coverage for ABMT procedures to be performed by Duke. After her final appeal for coverage under the Duke program was denied by Fallon, Mrs. Turner, on October 5, 1993, began chemotherapy treatment. Sadly, Mrs. Turner died on August 17, 1994.

II. PROCEDURAL HISTORY

Plaintiff filed a complaint in the Superior Court of Massachusetts, Worcester Division, on December 6, 1995, asserting claims of breach of contract, breach of implied covenant of good faith and fair dealing, wrongful death, loss of consortium, and negligent and/or intentional infliction of emotional distress. The case was removed to this Court on December 11, 1995, whereafter plaintiff amended his complaint to state a single claim of ERISA violations. Fallon moved for summary judgment on March 25, 1996, and shortly thereafter, plaintiff responded by filing the instant motion for a continuance or other relief pursuant to Fed.R.Civ.P. 56(f). Turner opposes that motion.

III. DISCUSSION

A. Applicable framework

Fed.R.Civ.P. 56(f) states that

Should it appear from the affidavits of a party opposing the motion [for summary judgment] that the party cannot for reasons stated present by affidavit facts essential to justify the party’s opposition, the court may refuse the application for judgment or may order a continuance to permit affidavits to be obtained or depositions to be taken or discovery to be had or may make such other order as is just.

To obtain relief under Rule 56(f), plaintiff must (1) provide an authoritative proffer of the facts required to be discovered, (2) provide that proffer in a- timely manner, (3) demonstrate good cause for his inability to adduce the facts essential to oppose the motion for summary judgment, (4) demonstrate the utility of the discovery, and (5) demonstrate the materiality of the facts. See Resolution Trust Corp. v. North Bridge Associates, Inc., 22 F.3d 1198, 1203-07 (1st Cir. 1994). The First Circuit has stated that these requirements

are not inflexible and that district courts are vested with considerable discretion in their administration. In the exercise of that discretion, one or more of the requirements may be relaxed, or even excused, to address the exigencies of a given case. When all five requirements are satisfied, however, a strong presumption arises in favor of relief. Unless the movant has been dilatory, or the court reasonably concludes that the motion is a stalling tactic or an exercise in futility, it should be treated liberally.

Id., at 1203 (citations omitted).

B. Legal analysis

Defendant does not dispute that plaintiff has made an authoritative proffer in a timely manner of the facts which plaintiff seeks to discover, so he must simply satisfy the final three prerequisites for relief under Rule 56(f) set forth in the North Bridge Associates decision.

[20]*201. Good cause for plaintiffs inability to adduce the facts essential to oppose defendant’s motion for summary judgment

Plaintiff has the burden of showing good cause for his inability to adduce the facts essential to oppose defendant’s motion for summary judgment in order to obtain a continuance under Rule 56(f). See North Bridge Associates, 22 F.3d at 1203-06; Paterson-Leitch Co., Inc. v. Massachusetts Municipal Wholesale Elec. Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
926 F. Supp. 17, 1996 U.S. Dist. LEXIS 6782, 1996 WL 257546, Counsel Stack Legal Research, https://law.counselstack.com/opinion/turner-v-fallon-community-health-plan-inc-mad-1996.